Measurement and correlation of solubility data for deferiprone in propylene glycol and 2-propanol at different temperatures.

Binary solvent mixtures Cosolvency models Deferiprone Thermodynamics solubility

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 24 04 2023
revised: 15 06 2023
accepted: 15 06 2023
medline: 10 7 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: epublish

Résumé

This investigation dealt with the thermodynamic properties, saturated solubility values, and solvation behavior of deferiprone as an oral iron chelator agent in non-aqueous mixtures of propylene glycol and 2-propanol using experimental measurements and mathematical correlations. The solubility of deferiprone demonstrated a positive correlation with both temperature and propylene glycol mass fraction. Four mathematical models were employed to correlate the solid-liquid equilibrium data, and the low mean relative deviation values of less than 3.6% illustrate the good agreement of computed data with the experimental data. The apparent thermodynamic behavior of deferiprone dissolution was also investigated according to van't Hoff and Gibbs equation.

Identifiants

pubmed: 37426787
doi: 10.1016/j.heliyon.2023.e17402
pii: S2405-8440(23)04610-8
pmc: PMC10329119
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e17402

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

Références

Lancet. 1989 Jul 1;2(8653):27-30
pubmed: 2567801
Eur J Pharm Sci. 2003 Aug;19(5):423-32
pubmed: 12907293
Paediatr Int Child Health. 2016 Aug;36(3):209-13
pubmed: 26052612
Platelets. 2020 May 18;31(4):505-512
pubmed: 31366263
J Pharm Sci. 1985 Feb;74(2):132-5
pubmed: 3989680
J Med Assoc Thai. 2001 Jul;84(7):929-41
pubmed: 11759973
J Pharm Sci. 2001 Nov;90(11):1838-58
pubmed: 11745742
J Pediatr Hematol Oncol. 2010 Nov;32(8):601-5
pubmed: 20921906
Int J Pharm. 1999 Jan 15;177(1):93-101
pubmed: 10205606
J Pharm Pharm Sci. 2008;11(1):32-58
pubmed: 18445363
Expert Opin Drug Metab Toxicol. 2006 Aug;2(4):591-608
pubmed: 16859407

Auteurs

Homa Rezaei (H)

Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Elaheh Rahimpour (E)

Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Fleming Martinez (F)

Grupo de Investigaciones Farmacéutico-Fisicoquímicas, Departamento de Farmacia, Universidad Nacional de Colombia, Sede Bogotá, Cra. 30 No. 45-03, Bogotá D. C., Colombia.

Abolghasem Jouyban (A)

Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Classifications MeSH